Skip to main content

Table 3 Relative risks for all-cause death in patients with SCH vs. ET

From: The impact of subclinical hypothyroidism on long-term outcomes in older patients undergoing percutaneous coronary intervention

 

Death(n)

Number at risk(n)

Unadjusted RR

95%CI

P Value

Adjusted RR

95%CI

P Value

ET

198

2848

1.000 (reference)

  

1.000 (reference)

  

SCH

29

320

1.323

0.896–1.954

0.159

1.261

0.802–1.982

0.315

Age<75 years

 ET

159

2276

1.000

  

1.000

  

 SCH

25

268

1.356

0.889–2.067

0.157

1.261

0.767–2.074

0.360

Age ≥ 75 years

 ET

39

572

1.000

  

1.000

  

 SCH

4

52

1.138

0.407–3.185

0.805

0.295

0.029–2.963

0.300

Male

 ET

124

1696

1.000

  

1.000

  

 SCH

12

132

1.248

0.690–2.256

0.464

1.037

0.523–2.058

0.917

Female

 ET

74

1152

1.000

  

1.000

  

 SCH

17

186

1.444

0.852–2.446

0.172

1.016

0.500–2.065

0.965

TSH

 0.34–5.60

198

2848

1.000

  

1.000

  

 5.61–9.99

24

278

1.255

0.822–1.918

0.293

1.275

0.767–2.121

0.349

≥10

5

42

1.749

0.720–4.248

0.217

1.062

0.322–3.497

0.921

  1. Adjusted RR: adjusted for age, gender, body mass index, hypertension, diabetes mellitus, hyperlipidemia, smoking, family history of coronary artery disease, History of myocardial infarction, history of percutaneous coronary intervention, history of the coronary artery bypass graft, history of stroke, history of heart failure, History of renal failure, acute myocardial infarction, left ventricle ejection fraction, hemoglobin, fasting glucose, creatinine, total cholesterol, triglyceride, low density lipoprotein cholesterol, high density lipoprotein cholesterol, high-sensitivity C-reactive protein, aspirin, clopidogrel, ß-Blocker, angiotensin II coenzyme inhibitor, angiotensin II receptor blocker, statins, multi-vessel disease, left main, left anterior descending, left circumflex artery, right coronary artery